| Time | Session |
|---|---|
| 1:00 pm – 1:05 pm | Welcome, roll call
Kara Elam, PhD, MPH, MS William H. Herman, MD, MPH |
| 1:05 pm – 1:20 pm | Opening Remarks
Dorothy Fink, MD |
| 1:20 pm – 1:25 pm | Review of the agenda
William H. Herman, MD, MPH |
| 1:25 pm – 1:40 pm | Executive Summary
|
| 1:40 pm – 1:55 pm | Chapter 1: Background
|
| 1:55 pm – 2:10 pm | Chapter 2: Methods
|
| 2:10 pm – 2:25 pm | Chapter 3: Foundational Recommendations to Address Diabetes in the U.S.
|
| 2:25 pm – 2:40 pm | Chapter 4: Population-Level Diabetes Prevention and Control
|
| 2:40 pm – 3:00 pm | BREAK |
| 3:00 pm – 3:15 pm | Chapter 5: Diabetes Prevention in Populations at High-Risk
|
| 3:15 pm – 3:30 pm | Chapter 6: Diabetes Treatment and Complications
|
| 3:30 pm – 3:45 pm | Chapter 7: Looking Forward (?)
|
| 3:45 pm – 3:55 pm | Appendices
|
| 3:55 pm – 4:05 pm | Table of Contents
|
| 4:05 pm – 4:35 pm | Oral Public Comments |
| 4:35 pm – 5:15 pm | Meeting Review, Next Steps, Concluding Remarks and Acknowledgments
William H. Herman, MD, MPH All Commission Members |
| 5:15 pm – 5:20 pm | Closing Remarks
Dorothy Fink, MD |
| 5:20 pm | Adjournment
Kara Elam, PhD, MPH, MS |
